MannKind News

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2024 FIRST QUARTER FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 5:00 p.m. (ET)

04:11

MannKind | DEFA14A: Others

Apr 5 18:12

MannKind | DEF 14A: Definitive information statements

Apr 5 18:08

MannKind | 8-K: Current report

Apr 4 05:00

MannKind | 8-K: Current report

Mar 27 04:16

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 5:00 p.m. (ET)

Feb 28 05:07

MannKind | 8-K: Current report

Jan 2 13:00

MannKind | 8-K: Current report

Dec 27, 2023 13:00

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2023 THIRD QUARTER FINANCIAL RESULTS Conference Call to Begin Today at 5:00 p.m. (ET)

Nov 8, 2023 05:05

MannKind | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 24, 2023 04:52

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2023 SECOND QUARTER FINANCIAL RESULTS Conference Call to Begin Today at 5:00 p.m. (ET)

Aug 8, 2023 04:06

MannKind | 8-K: Current report

Jul 1, 2023 06:00

MannKind | 8-K: Current report

May 31, 2023 04:07

MannKind | 8-K/A: MANNKIND CORPORATION REPORTS 2023 FIRST QUARTER FINANCIAL RESULTS Conference Call to Begin Today at 5:00 p.m. (ET)

May 10, 2023 09:00

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2023 FIRST QUARTER FINANCIAL RESULTS Conference Call to Begin Today at 5:00 p.m. (ET)

May 10, 2023 04:06

MannKind | DEFA14A: Others

Apr 14, 2023 20:01

MannKind | DEFA14A: Others

Apr 11, 2023 18:05

MannKind | DEF 14A: Definitive proxy statements

Apr 11, 2023 05:01

MannKind | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Mar 31, 2023 05:01

MannKind | 8-K: Current report

Mar 28, 2023 04:18